Female and Male Infertility

Nurses' Virtual Workshop in medically assisted reproduction:

Advancing education & training, pharmacological management and evidence-based practice (novel investigations & treatments)

22 November 2024 (CME)
from 13.00 to 17.00 CET


This online workshop focuses on the real-world application of research evidence, clinical guidelines and management systems, to improve the diagnosis, treatment and support of people seeking medically assisted reproduction (MAR). After reviewing the evidence, attendees will evaluate markers of infertility and select responses they perceive to be important for specific situations. They will also consider expert opinions and debated topics in relation to current evidence-based medicine. Measures of success will be discussed that support patient engagement, development of individualised treatment plans and best clinical practices. The ultimate goal of the workshop is for fertility nurses (and midwives with an interest in fertility medicine) to promote patient-centred care, through delivering holistic, advanced fertility nursing/midwifery practice.

Demand for MAR is increasing, globally, in part because of the well-described almost global decline in birth rates and the increasing female age at first pregnancy. While advances in MAR have improved thediagnostic and treatment options available in many countries, novel processes and add-ons have also increased patient expectations for treatment success. Managing individual’s expectations is among the extended roles of fertility nurses and midwives, and for people who are undergoing MAR it demands a higher level of post-registration education and training. Such training includes advanced understanding of the pathophysiology, justification, intended effects, side-effects and contraindications of pharmaceutical products used in MAR: this is essential to provide fertility care safely. Fertility nurses and midwives have key roles in the MAR team, where multidisciplinary teamwork is essential for the delivery of integrated quality patient care. There is an expectation that all health professionals involved in MAR will attain – and maintain – their full potential in accordance with their job description, role, clinical knowledge and professional competency.

The extended roles and responsibilities of fertility nurses and midwives also entail excellent communication skills with patients and the wider multidisciplinary team (i.e., clinical, laboratory, administrative and counselling colleagues), in addition to specialists in oncology, gynaecology, endocrinology departments as appropriate. Therefore, it is essential that nurses and midwives have a good awareness of current evidence-based investigations and treatments that are allied to fertility services, so that they know how to support individual patients with multiple needs appropriately.This unique MedEA programme is CME- and Royal College of Nursing (RCN)-accredited and provides continuous professional development (CPD) credits that meet the requirement for assessment and competency in professional practice (in accordance with professional nursing standards). 

Learning Objectives

After participating in this workshop and related activities, delegates will:

Target Audience

Nurses and midwives working in fertility or early pregnancy settings who wish to advance their professional and clinical practice; update their knowledge of advanced, evidence-based techniques; and improve their understanding of the pathophysiology and role of pharmaceutical products used in medically assisted reproduction (MAR).


An application for this worskhop will be made to the Royal College of Nursing (RCN) – Accreditation applies only to the educational content and not to any product. The RCN cannot confirm the competence of any practitioner.

This programme will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).

This programme will be submitted for accreditation to The CPD Certification Service, UK.

Nurses' Virtual Workshop in medical assisted reproduction

Continuing Medical Education (CME)

22 November 2024
from 13.00 to 17.00 CET


Katie Best

The Hewitt Fertility Centre
Liverpool Women's Hospital
Liverpool, UK

Tim Child

Medical Director
Oxford Fertility Unit
Oxford, UK

Hilde Cotton

Fertility Nurse at Klinikk Hausken
Oslo, Norway

Louise Dias

KU Leuven, Regeneration and Development
Leuven, Belgium

Robert Fischer

Fertility Center Hamburg
Hamburg, Germany

Helen Kendrew

CARE fertility Bath
Bath, UK

Valerie Peddie

University of Aberdeen
School of Medicine, Medical Sciences & Nutrition
Aberdeen, Scotland

Jennifer Ulyatt

Fertility Nurse Specialist and Sedationist
NHS Tayside
Dundee, Scotland

Scientific Programme


· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.